Literature DB >> 19933107

Breaking the code of DNA binding specificity of TAL-type III effectors.

Jens Boch1, Heidi Scholze, Sebastian Schornack, Angelika Landgraf, Simone Hahn, Sabine Kay, Thomas Lahaye, Anja Nickstadt, Ulla Bonas.   

Abstract

The pathogenicity of many bacteria depends on the injection of effector proteins via type III secretion into eukaryotic cells in order to manipulate cellular processes. TAL (transcription activator-like) effectors from plant pathogenic Xanthomonas are important virulence factors that act as transcriptional activators in the plant cell nucleus, where they directly bind to DNA via a central domain of tandem repeats. Here, we show how target DNA specificity of TAL effectors is encoded. Two hypervariable amino acid residues in each repeat recognize one base pair in the target DNA. Recognition sequences of TAL effectors were predicted and experimentally confirmed. The modular protein architecture enabled the construction of artificial effectors with new specificities. Our study describes the functionality of a distinct type of DNA binding domain and allows the design of DNA binding domains for biotechnology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933107     DOI: 10.1126/science.1178811

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  928 in total

Review 1.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

2.  The iCRISPR platform for rapid genome editing in human pluripotent stem cells.

Authors:  Zengrong Zhu; Federico González; Danwei Huangfu
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 3.  Determining the specificities of TALENs, Cas9, and other genome-editing enzymes.

Authors:  Vikram Pattanayak; John P Guilinger; David R Liu
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 4.  Gene therapy using stem cells.

Authors:  Erin R Burnight; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-13       Impact factor: 6.915

Review 5.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

6.  Genomic analysis of Xanthomonas oryzae isolates from rice grown in the United States reveals substantial divergence from known X. oryzae pathovars.

Authors:  L R Triplett; J P Hamilton; C R Buell; N A Tisserat; V Verdier; F Zink; J E Leach
Journal:  Appl Environ Microbiol       Date:  2011-04-22       Impact factor: 4.792

7.  From perception to activation: the molecular-genetic and biochemical landscape of disease resistance signaling in plants.

Authors:  Caleb Knepper; Brad Day
Journal:  Arabidopsis Book       Date:  2010-05-14

Review 8.  Bacterial effectors target the plant cell nucleus to subvert host transcription.

Authors:  Joanne Canonne; Susana Rivas
Journal:  Plant Signal Behav       Date:  2012-02-01

9.  Structural modeling of TAL effector-DNA interactions.

Authors:  Philip Bradley
Journal:  Protein Sci       Date:  2012-02-14       Impact factor: 6.725

Review 10.  Synthetic biology in mammalian cells: next generation research tools and therapeutics.

Authors:  Florian Lienert; Jason J Lohmueller; Abhishek Garg; Pamela A Silver
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01-17       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.